A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in the Journal of Veterinary Internal Medicine, offers new hope for the management of chronic kidney disease (CKD) in dogs. The research highlights the potential benefits of paricalcitol, a second-generation vitamin D analog, in addressing renal secondary hyperparathyroidism (RHPT) and proteinuria—two critical complications of CKD. A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in the Journal of Veterinary Internal Medicine, offers new hope for the management of chronic kidney disease (CKD) in dogs. The research highlights the potential benefits of paricalcitol, a second-generation vitamin D analog, in addressing renal secondary hyperparathyroidism (RHPT) and proteinuria—two critical complications of CKD. Veterinary medicine Phys.org – latest science and technology news stories
Potential treatment for chronic kidney disease in dogs developed
